Ignite Creation Date:
2025-12-25 @ 4:05 AM
Ignite Modification Date:
2025-12-26 @ 3:00 AM
Study NCT ID:
NCT00964002
Status:
COMPLETED
Last Update Posted:
2022-05-16
First Post:
2009-08-21
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Efavirenz in Treating Patients With Metastatic Prostate Cancer
Sponsor:
Institut Bergonié
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-05
Start Date Type:
ACTUAL
Primary Completion Date:
2011-09-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-04-08
Completion Date Type:
ACTUAL
First Submit Date:
2009-08-21
First Submit QC Date:
None
Study First Post Date:
2009-08-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-11-25
Results First Submit QC Date:
None
Results First Post Date:
2022-05-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-01
Last Update Post Date:
2022-05-16
Last Update Post Date Type:
ACTUAL